News

Hosts starve their microbial denizens of nutrients, essentially enslaving the microbes in their gut so that they are forced to do our bidding.

Researchers are always seeking more reliable and more efficient communications, for everything from televisions and cellphones to satellites and medical devices. However, some of the most exciting techniques are highly energy demanding. Now, researchers are using brain-inspired machine learning techniques to increase the energy efficiency of wireless receivers to make communications greener.

DNA-damaging agents, or "DDAs," make up the most widely used group of cancer drugs. Yet their therapeutic success has been curtailed by drug resistance. Now, biologists have discovered a new way of re-sensitizing drug-resistant human tumor cells to the potency of DDAs.

Widespread immunity to the Cas9 protein, hailed as the gene therapy silver bullet, raises concerns over safety in some people.

A systematic review of research has revealed that the toxic effects on the lung of drugs commonly taken to treat a range of common conditions is much more widespread than thought.

Pathway identified which affects stress-induced lipid metabolism, implicates epigenetic dysregulation in relevant human diseases.

LSD changes the communication patterns between regions of the brain, a new study by researchers of the University of Zurich and Yale University shows. The study also provides insights into how mental health disorders develop and how these could be treated.

Ocean acidification caused by high levels of human-made CO2 is dissolving the seafloor, raising concerns for the future.

Linking therapeutically active molecules to specific antibodies can help to pilot them to their designated targets and minimize side effects - especially when treating tumors. Scientists have now described novel conjugates made from antibodies and a kinesin spindle protein inhibitor. Changing the linker between the two components allows for tuning the activity of this cytostatic drug, which is effective against a broad palette of cancers.

The National Center for Tumor Diseases (NCT) Heidelberg and Protagen AG extend their collaboration to investigate the immuno-competence of urothelial cancer patients receiving immunotherapy.